JP2006526596A5 - - Google Patents

Download PDF

Info

Publication number
JP2006526596A5
JP2006526596A5 JP2006508355A JP2006508355A JP2006526596A5 JP 2006526596 A5 JP2006526596 A5 JP 2006526596A5 JP 2006508355 A JP2006508355 A JP 2006508355A JP 2006508355 A JP2006508355 A JP 2006508355A JP 2006526596 A5 JP2006526596 A5 JP 2006526596A5
Authority
JP
Japan
Prior art keywords
piperazin
phenyl
methanone
imidazol
pyrrol
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2006508355A
Other languages
English (en)
Japanese (ja)
Other versions
JP4805813B2 (ja
JP2006526596A (ja
Filing date
Publication date
Priority claimed from FR0306719A external-priority patent/FR2855825B1/fr
Application filed filed Critical
Priority claimed from PCT/FR2004/001379 external-priority patent/WO2004108685A1/fr
Publication of JP2006526596A publication Critical patent/JP2006526596A/ja
Publication of JP2006526596A5 publication Critical patent/JP2006526596A5/ja
Application granted granted Critical
Publication of JP4805813B2 publication Critical patent/JP4805813B2/ja
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

JP2006508355A 2003-06-04 2004-06-03 アリール−ヘテロ芳香族生成物、それらを含む組成物及びその使用 Expired - Fee Related JP4805813B2 (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
FR03/06719 2003-06-04
FR0306719A FR2855825B1 (fr) 2003-06-04 2003-06-04 Produits aryl-heteroaromatiques, compositions les contenant et utilisation
FR0404889 2004-05-06
FR04/04889 2004-05-06
PCT/FR2004/001379 WO2004108685A1 (fr) 2003-06-04 2004-06-03 Produits aryl-heteroaromatiques, compositions les contenant et utilisation

Publications (3)

Publication Number Publication Date
JP2006526596A JP2006526596A (ja) 2006-11-24
JP2006526596A5 true JP2006526596A5 (https=) 2007-07-05
JP4805813B2 JP4805813B2 (ja) 2011-11-02

Family

ID=33512659

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2006508355A Expired - Fee Related JP4805813B2 (ja) 2003-06-04 2004-06-03 アリール−ヘテロ芳香族生成物、それらを含む組成物及びその使用

Country Status (16)

Country Link
US (1) US20050014765A1 (https=)
EP (1) EP1641765A1 (https=)
JP (1) JP4805813B2 (https=)
KR (1) KR20060006850A (https=)
AR (1) AR044586A1 (https=)
AU (1) AU2004245269A1 (https=)
BR (1) BRPI0411001A (https=)
CA (1) CA2528093A1 (https=)
CL (1) CL2004001359A1 (https=)
IL (1) IL172222A0 (https=)
MX (1) MXPA05012929A (https=)
PA (1) PA8604401A1 (https=)
PE (1) PE20050226A1 (https=)
TW (1) TW200510344A (https=)
UY (1) UY28350A1 (https=)
WO (1) WO2004108685A1 (https=)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20050119251A1 (en) * 2001-12-21 2005-06-02 Jian-Min Fu Nicotinamide derivatives and their use as therapeutic agents
AU2005286790A1 (en) * 2004-09-20 2006-03-30 Xenon Pharmaceuticals Inc. Bicyclic heterocyclic derivatives and their use as inhibitors of stearoyl-CoA-desaturase (SCD)
BRPI0515482A (pt) * 2004-09-20 2008-07-22 Xenon Pharmaceuticals Inc derivados heterocìclicos e seus usos como agentes terapêuticos
BRPI0515500A (pt) * 2004-09-20 2008-07-29 Xenon Pharmaceuticals Inc derivados piridazina para inibição de estearoil-coa-desaturase
EP1827438B2 (en) * 2004-09-20 2014-12-10 Xenon Pharmaceuticals Inc. Piperazin derivatives for inhibiting human stearoyl-coa-desaturase
MX2007003332A (es) * 2004-09-20 2007-06-05 Xenon Pharmaceuticals Inc Derivados heterociclicos y su uso como inhibidores de estearoil-coa-desaturasa.
CN101084211A (zh) * 2004-09-20 2007-12-05 泽农医药公司 杂环衍生物及其作为治疗剂的用途
AU2005286647A1 (en) 2004-09-20 2006-03-30 Xenon Pharmaceuticals Inc. Heterocyclic derivatives and their use as stearoyl-CoA desaturase inhibitors
MX2007003318A (es) 2004-09-20 2007-05-18 Xenon Pharmaceuticals Inc Derivados heterociclicos y su uso como agentes terapeuticos.
AU2005286728A1 (en) * 2004-09-20 2006-03-30 Xenon Pharmaceuticals Inc. Heterocyclic derivatives and their use as mediators of stearoyl-CoA desaturase
CA2618646A1 (en) 2005-06-03 2007-11-15 Xenon Pharmaceuticals Inc. Aminothiazole derivatives as human stearoyl-coa desaturase inhibitors
TW200800946A (en) * 2005-08-15 2008-01-01 Astrazeneca Ab Substituted piperazines as metabotropic glutamate receptor antagonists
CA2648748A1 (en) * 2006-04-14 2007-10-25 Takeda Pharmaceutical Company Limited Nitrogen-containing heterocyclic compound
DE102006027229A1 (de) * 2006-06-09 2007-12-20 Grünenthal GmbH 1,3-Disubstituierte 4-Methyl-1H-pyrrol-2-carbonsäureamide und ihre Verwendung zur Herstellung von Arzneimitteln
US8148367B2 (en) * 2007-01-12 2012-04-03 Takeda Pharmaceutical Company Limited Renin inhibitors
WO2009117444A1 (en) * 2008-03-17 2009-09-24 Northeastern University Inhibitors of fatty acid amide hydrolase and monoacylglycerol lipase for modulation of cannabinoid receptors
MX342128B (es) 2008-12-24 2016-09-14 Bial - Portela & C A S A Compuestos farmaceuticos.
KR101297652B1 (ko) * 2010-11-25 2013-08-19 한국과학기술연구원 항암활성을 지닌 카르보아졸계 화합물
US20140343017A1 (en) * 2012-01-25 2014-11-20 Kabushiki Kaisha Yakult Honsha Pyrrole compound
ES2617863T3 (es) 2012-06-04 2017-06-20 Actelion Pharmaceuticals Ltd. Derivados de bencimidazol-prolina
EA201500399A1 (ru) 2012-10-10 2015-09-30 Актелион Фармасьютиклз Лтд. Антагонисты рецептора орексина, которые представляют собой производные [орто-би-(гетеро)арил]-[2-(мета-би-(гетеро)арил)пирролидин-1-ил]метанона
CA2902135A1 (en) 2013-03-12 2014-09-18 Actelion Pharmaceuticals Ltd Azetidine amide derivatives as orexin receptor antagonists
SI3077391T1 (sl) 2013-12-04 2018-11-30 Idorsia Pharmaceuticals Ltd Uporaba benzimidazol-prolinskih derivatov
WO2020194326A1 (en) 2019-03-28 2020-10-01 Council Of Scientific And Industrial Research Process for the preparation of tapentadol and analogs thereof

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE69628559T2 (de) * 1995-04-07 2004-04-29 Schering Corp. Carbonyl-piperaznyl und piperidinyl derivate zur hemmung farnesyl protein transferase
US5880128A (en) * 1996-05-08 1999-03-09 Schering Corporation Carbonyl piperazinyl and piperidinyl compounds
DE10035908A1 (de) * 2000-07-21 2002-03-07 Asta Medica Ag Neue Heteroaryl-Derivate und deren Verwendung als Arzneimittel
DE10035927A1 (de) * 2000-07-21 2002-03-07 Asta Medica Ag Neue Heteroaryl-Derivate und deren Verwendung als Arzneimittel
DE10035928A1 (de) * 2000-07-21 2002-03-07 Asta Medica Ag Neue Heteroaryl-Derivate und deren Verwendung als Arzneimittel
FR2815032B1 (fr) * 2000-10-10 2003-08-08 Pf Medicament Nouveaux derives d'aminophenyle piperazine ou d'amino phenyle piperide inhibiteurs de proteines prenyl transferase ainsi que leurs preparations
UA79286C2 (en) * 2002-06-29 2007-06-11 Zentaris Gmbh Arylcarbonylpipererazines and heteroarylcarbonylpiperazines and their use in the treatment of benign and malignant tumors
AU2003287965A1 (en) * 2002-10-24 2004-05-13 Carex Sa Modulation of peroxisome proliferator activated receptors activity
GB0228417D0 (en) * 2002-12-05 2003-01-08 Cancer Rec Tech Ltd Pyrazole compounds

Similar Documents

Publication Publication Date Title
JP2006526596A5 (https=)
JP2013517283A5 (https=)
JP2008517945A5 (https=)
JP2005539000A5 (https=)
JP2004504301A5 (https=)
JP2020521730A5 (https=)
JP2004518725A5 (https=)
JP2006510728A5 (https=)
JP2007501264A5 (https=)
JP2004521087A5 (https=)
JP2009519967A5 (https=)
RU2008112221A (ru) Соединения ряда изоиндолимидов, их композиции и способы применения
JP2007531753A5 (https=)
JP2019537594A5 (https=)
JP2012510989A5 (https=)
JP2010529991A5 (https=)
JP2010513304A5 (https=)
JP2016164184A5 (https=)
RU2007124935A (ru) АМИНОПИРИДИНЫ В КАЧЕСТВЕ ИНГИБИТОРОВ β-СЕКТРЕТАЗЫ
RU2007134441A (ru) Пиридильное неароматическое азотсодержащее гетероцикло-1-карбоксилатное производное
JP2020516671A5 (https=)
JP2013542937A5 (https=)
JP2008525502A5 (https=)
RU2004112191A (ru) Лактамсодержащие соединения и их производные в качестве ингибиторов фактора ха
JP2008500284A5 (https=)